Randomised controlled field study to evaluate the efficacy and clinical safety of a single 8 mg/kg injectable dose of marbofloxacin compared with one or two doses of 7.5 mg/kg injectable enrofloxacin for the treatment of Actinobacillus pleuropneumoniae infections in growing-fattening pigs in Europe

BACKGROUND: Acute outbreaks of Actinobacillus pleuropneumoniae (APP) require rapid, effective, parenteral antimicrobial treatment. The efficacy and safety of a single, short-acting, high dose of marbofloxacin (Forcyl® swine 160 mg/mL) compared with 1 or 2 doses of 7.5 mg/kg enrofloxacin in APP outbr...

Descripción completa

Detalles Bibliográficos
Autores principales: Grandemange, Erik, Perrin, Pierre-Alexandre, Cvejic, Dejean, Haas, Miriam, Rowan, Tim, Hellmann, Klaus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5424389/
https://www.ncbi.nlm.nih.gov/pubmed/28496988
http://dx.doi.org/10.1186/s40813-017-0057-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5424389/
https://www.ncbi.nlm.nih.gov/pubmed/28496988
http://dx.doi.org/10.1186/s40813-017-0057-2

Ejemplares similares